An increased release of SFA in the tumour microenvironment stimulates macrophages to manufacture pro-inflammatory mediators, including cyclooxygenase-2 and tumour necrosis factor alpha42, leading to enhanced aromatase expression in adipocytes and sustained oestrogen biosynthesis for tumour progression43,44. This evidence concerns the gene CYP19A1 and neoplasm.